Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 4366 AL 4380

ASURE Clinical Trial Protocol: A Randomized, Placebo-Controlled, Proof-of-Concept Study Aiming to Evaluate Safety and Target Engagement following Administration of TW001 in Early Alzheimer's Disease Patients

Oosthoek M, Lili A, Almeida A, van Loosbroek O, van der Geest R, de Greef-van der Sandt I, van Bokhoven P, Sikkes SAM, Teunissen CE, Vijverberg EGB.

J Prev Alzheimers Dis. 2023;10(4):669-674. doi: 10.14283/jpad.2023.107.

The Critical Role of Biomarkers for Drug Development Targeting the Biology of Aging

Owen M, Bose N, Nisenbaum L, Partrick KA, Fillit HM.

J Prev Alzheimers Dis. 2023;10(4):729-742. doi: 10.14283/jpad.2023.111.

Two-Year Prognostic Utility of Plasma p217+tau across the Alzheimer's Continuum

Feizpour A, Doré V, Doecke JD, Saad ZS, Triana-Baltzer G, Slemmon R, Maruff P, Krishnadas N, Bourgeat P, Huang K, Fowler C, Rainey-Smith SR, Bush AI, Ward L, Robertson J, Martins RN, Masters CL, Villemagne VL, Fripp J, Kolb HC, Rowe CC.

J Prev Alzheimers Dis. 2023;10(4):828-836. doi: 10.14283/jpad.2023.83.

Exploratory Tau Biomarker Results From a Multiple Ascending-Dose Study of BIIB080 in Alzheimer Disease: A Randomized Clinical Trial

Edwards AL, Collins JA, Junge C, Kordasiewicz H, Mignon L, Wu S, Li Y, Lin L, DuBois J, Hutchison RM, Ziogas N, Shulman M, Martarello L, Graham D, Lane R, Budd Haeberlein S, Beaver J.

JAMA Neurol. 2023 Dec 1;80(12):1344-1352. doi: 10.1001/jamaneurol.2023.3861.

Required improvements for cerebrospinal fluid-based biomarker tests of Alzheimer's disease

Gaetani L, Chiasserini D, Paolini Paoletti F, Bellomo G, Parnetti L.

Expert Rev Mol Diagn. 2023 Jul-Dec;23(12):1195-1207. doi: 10.1080/14737159.2023.2276918. Epub 2023 Dec 15.

Comparative methods for quantifying plasma biomarkers in Alzheimer's disease: Implications for the next frontier in cerebral amyloid angiopathy diagnostics

Muir RT, Ismail Z, Black SE, Smith EE.

Alzheimers Dement. 2024 Feb;20(2):1436-1458. doi: 10.1002/alz.13510. Epub 2023 Oct 31.

Comparison of CSF and plasma NfL and pNfH for Alzheimer's disease diagnosis: a memory clinic study

Vrillon A, Ashton NJ, Karikari TK, Götze K, Cognat E, Dumurgier J, Lilamand M, Zetterberg H, Blennow K, Paquet C.

J Neurol. 2024 Mar;271(3):1297-1310. doi: 10.1007/s00415-023-12066-6. Epub 2023 Nov 11.

Innovative SALDI mass spectrometry analysis for Alzheimer's disease synthetic peptides detection

Cournut A, Moustiez P, Coffinier Y, Enjalbal C, Bich C.

Talanta. 2024 Feb 1;268(Pt 2):125357. doi: 10.1016/j.talanta.2023.125357. Epub 2023 Nov 2.

Molecular biomarkers for vascular cognitive impairment and dementia

Hosoki S, Hansra GK, Jayasena T, Poljak A, Mather KA, Catts VS, Rust R, Sagare A, Kovacic JC, Brodtmann A, Wallin A, Zlokovic BV, Ihara M, Sachdev PS.

Nat Rev Neurol. 2023 Dec;19(12):737-753. doi: 10.1038/s41582-023-00884-1. Epub 2023 Nov 13.

Potential Retinal Biomarkers in Alzheimer's Disease

García-Bermúdez MY, Vohra R, Freude K, Wijngaarden PV, Martin K, Thomsen MS, Aldana BI, Kolko M.

Int J Mol Sci. 2023 Oct 31;24(21):15834. doi: 10.3390/ijms242115834.

Correlations between insulin-degrading enzyme and metabolic markers in patients diagnosed with type 2 diabetes, Alzheimer's disease, and healthy controls: a comparative study

Kullenberg H, Rossen J, Johansson UB, Hagströmer M, Nyström T, Kumlin M, Svedberg MM.

Endocrine. 2024 May;84(2):450-458. doi: 10.1007/s12020-023-03603-4. Epub 2023 Nov 18.

Alzheimer's Disease Biomarker Detection Using Field Effect Transistor-Based Biosensor

Le PG, Choi SH, Cho S.

Biosensors (Basel). 2023 Nov 17;13(11):987. doi: 10.3390/bios13110987.

Circulating arginine metabolites in Alzheimer's disease and vascular dementia: A systematic review and meta-analysis

Zinellu A, Tommasi S, Sedda S, Mangoni AA.

Ageing Res Rev. 2023 Dec;92:102139. doi: 10.1016/j.arr.2023.102139. Epub 2023 Nov 23.

Physical Performance and Amyloid-β in Humans: A Systematic Review and Meta-Analysis of Observational Studies

Solis-Urra P, Rodriguez-Ayllon M, Álvarez-Ortega M, Molina-Hidalgo C, Molina-Garcia P, Arroyo-Ávila C, García-Hermoso A, Collins AM, Jain S, Gispert JD, Liu-Ambrose T, Ortega FB, Erickson KI, Esteban-Cornejo I.

J Alzheimers Dis. 2023;96(4):1427-1439. doi: 10.3233/JAD-230586.

Clusterin is a Potential Therapeutic Target in Alzheimer's Disease

Palihati N, Tang Y, Yin Y, Yu D, Liu G, Quan Z, Ni J, Yan Y, Qing H.

Mol Neurobiol. 2024 Jul;61(7):3836-3850. doi: 10.1007/s12035-023-03801-1. Epub 2023 Nov 29.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias